Total
0
Shares
Nutritional High (CSE:EAT) appoints CEO and Senior Scientific Advisor of psychedelics business unit
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Nutritional High (EAT) has appointed a CEO and a Senior Scientific Advisor to its psychedelics business unit
  • Walker Bass will become CEO of the company's wholly-owned subsidiary Psychedelic Science Corp
  • Bass is a seasoned sales and business development executive with over 25 years of experience
  • He will focus on developing products based on whole plant extract as well as identifying and developing compounds from psychedelic cacti
  • The company's new Senior Scientific Advisor has extensive experience in biopharmaceuticals, natural health products and product development
  • Nutritional High is focused on developing and manufacturing branded products in the cannabis industry
  • Nutritional High (EAT) is up by 25 per cent and is currently trading at $0.025 per share

Nutritional High (EAT) has appointed a CEO and a Senior Scientific Advisor to its psychedelics business unit.

Walker Bass will become CEO of the company's wholly-owned subsidiary Psychedelic Science Corp.

Bass is a seasoned sales and business development executive with over 25 years of experience. He served executive roles at firms such as NASDAQ OMX Group and Ernst & Young. He also served in the Office of Presidential Personnel at The White House.

Bass will focus on developing products based on whole plant extract as well as seeking partnership opportunities in the pharmaceutical market to identify and develop compounds from psychedelic cacti.

His path will focus on securing approval from the U.S. Food and Drug Administration for the treatment of diseases with high unmet medical needs.

The company has also appointed a Senior Scientific Advisor with extensive experience in biopharmaceuticals, natural health products and product development.

With prior roles leading clinical research operations teams across a wide range of indications, the advisor will assist Bass with product development, strategic scientific planning and managing external contract research.

John Durfy, CEO of Nutritional High, commented,

"We are very pleased to have Mr. Bass join the team and lead the initiatives at Psychedelic Science. With the support of our Scientific Advisor, the core team is now established in order to develop and expand the PSC business, with a focus on data and evidence generation."

Nutritional High is focused on developing and manufacturing branded products in the cannabis industry.

Nutritional High (EAT) is up by 25 per cent and is currently trading at $0.025 per share as of 1:00 pm ET.

More From The Market Herald
Clearmind Medicine (CSE:CMND) announces closing of private placement

" Clearmind Medicine (CSE:CMND) partners with The Hebrew University

Clearmind Medicine (CMND) has established a research and development partnership with the Yissum Research Development Company.
Sprout AI (CSE:SPRT) receives $2.1 million purchase order

" Sprout AI (CSE:SPRT) announces initial sales order

Sprout AI (SPRT) has been selected by JT Medical to provide cultivation technology for controlled substances.
Small Pharma - CEO, Peter Rands (third from left) and the Small Pharma team. - The Market Herald Canada

" Negev Capital doubles down on Small Pharma (TSXV:DMT)

Negev Capital, a psychedelic medical intervention fund, has doubled its investment in Small Pharma (DMT).
TransCanna (CSE:TCAN) achieves milestone with its first harvest at Daly Facility

" TransCanna (CSE:TCAN) achieves milestone with its first harvest at Daly Facility

TransCanna (TCAN) has completed its first harvest at its Daly Facility, marking a major milestone for the company.